0.67
Curanex Pharmaceuticals Inc Borsa (CURX) Ultime notizie
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Curanex Pharmaceuticals IncCommon Stock (NQ: CURX - FinancialContent
Curanex Pharmaceuticals (CURX): An Emerging Force in US Botanical Drug Development - FinancialContent
Curanex Pharmaceuticals (CURX): An Emerging Force In US Botanical Drug Development - Menafn.com
Curanex engages Strategic Investor Relations to enhance Curanex’s visibility - TipRanks
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement - The Manila Times
Curanex Pharmaceuticals Inc. Engages Strategic Investor - GlobeNewswire
Price performance - Yahoo
Curanex Pharmaceuticals Inc trading resumes - MSN
Curanex Pharmaceuticals Issues Shares Post-IPO - TipRanks
Curanex Pharmaceuticals issues shares in private placement and repays insider loans - Investing.com
Curanex Pharmaceuticals Inc’s Quiet Period To End on October 6th (NASDAQ:CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) company profile and facts - Yahoo! Finance UK
Day 5 of Loss Streak for Curanex Pharmaceuticals Stock with -89% Return (vs. 64% YTD) [9/23/2025] - Trefis
Jun Liu Net Worth (2025) - GuruFocus
RXRX Stock Surges: What’s Next? - StocksToTrade
CURX Pharmaceuticals: A New Dawn or a Passing Surge? - StocksToTrade
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Inc trading halted, volatility trading pause - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.57% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.57% - Investing.com
Technical Analysis of Curanex Pharmaceuticals Inc (NASDAQ:CURX) - TradingView
Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - Citeline News & Insights
Chinese Stocks To Follow Now – September 11th - Defense World
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Boosts IPO Proceeds with Share Sale - TipRanks
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters - GlobeNewswire
$17.25M IPO Complete: Biotech Curanex Pharmaceuticals Secures Full Over-Allotment Exercise at $4/Share - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biopharma IPO activity slows, but 2025 returns are surging - BioWorld MedTech
Number of employees of Curanex Pharmaceuticals Inc – BOATS:CURX - TradingView
Curanex Pharmaceuticals Inc Financial Statements – NASDAQ:CURX - TradingView
Finance Watch: Ever The Outlier, Biotech Outpaces Broader Stocks - insights.citeline.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):